ACHV
Achieve Life Sciences Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
achieve life sciences is a specialty pharmaceutical company committed to advancing cytisine as a smoking cessation aid to overcome the global nicotine addiction epidemic.
Market Cap: 90.8 Million
Primary Exchange: NASDAQ
Website: http://achievelifesciences.com/
Shares Outstanding: 21.1 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.1166259419841045
Sector: Manufacturing
Industry: In-Vitro Diagnostic Substance Manufacturing
Ethical Flags
Longest drawdown: 2682 trading days
From: 2014-03-10 To: 2023-09-29
Lowest Point:
Healthcare tops midday movers
via: SeekingAlpha at 2019-06-11 08:41:05:000
Gainers: Jaguar Health (NASDAQ: JAGX ) +60% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +40% . TORM (NASDAQ: TRMD ) +20% . Rekor Systems, Inc. (REKR) +17% . Enzo Biochem, Inc. (NYSE: ENZ ) +17% . Oxbridge Re Holdings (NASDAQ: OXBR ) +16% . Tenax Therapeutics (NASDAQ: TENX ) +1… read more...
Healthcare tops midday movers
via: SeekingAlpha at 2019-06-11 08:41:05:000
Gainers: Jaguar Health (NASDAQ: JAGX ) +60% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +40% . TORM (NASDAQ: TRMD ) +20% . Rekor Systems, Inc. (REKR) +17% . Enzo Biochem, Inc. (NYSE: ENZ ) +17% . Oxbridge Re Holdings (NASDAQ: OXBR ) +16% . Tenax Therapeutics (NASDAQ: TENX ) +1… read more...
Healthcare tops midday movers
via: SeekingAlpha at 2019-06-11 08:41:05:000
Gainers: Jaguar Health (NASDAQ: JAGX ) +60% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +40% . TORM (NASDAQ: TRMD ) +20% . Rekor Systems, Inc. (REKR) +17% . Enzo Biochem, Inc. (NYSE: ENZ ) +17% . Oxbridge Re Holdings (NASDAQ: OXBR ) +16% . Tenax Therapeutics (NASDAQ: TENX ) +1… read more...
HDS, SYMC and BYND among premarket losers
via: SeekingAlpha at 2019-06-11 05:16:59:000
CymaBay Therapeutics (NASDAQ: CBAY ) -45% on disappointing data on NASH candidate seladelpar. More news on: CymaBay Therapeutics, Inc., Achieve Life Sciences, Inc., Beyond Meat, Inc., Stocks on the move, Read more … read more...
HDS, SYMC and BYND among premarket losers
via: SeekingAlpha at 2019-06-11 05:16:59:000
CymaBay Therapeutics (NASDAQ: CBAY ) -45% on disappointing data on NASH candidate seladelpar. More news on: CymaBay Therapeutics, Inc., Achieve Life Sciences, Inc., Beyond Meat, Inc., Stocks on the move, Read more … read more...
HDS, SYMC and BYND among premarket losers
via: SeekingAlpha at 2019-06-11 05:16:59:000
CymaBay Therapeutics (NASDAQ: CBAY ) -45% on disappointing data on NASH candidate seladelpar. More news on: CymaBay Therapeutics, Inc., Achieve Life Sciences, Inc., Beyond Meat, Inc., Stocks on the move, Read more … read more...
Achieve Life Sciences up 16% premarket on positive cytisinicline data
via: SeekingAlpha at 2019-06-11 04:13:28:000
Achieve Life Sciences (NASDAQ: ACHV ) is up 16% premarket on robust volume in response to results from the Phase 2 ORCA-1 dose-selection study of cytisinicline for smoking cessation. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Cons… read more...
Achieve Life Sciences up 16% premarket on positive cytisinicline data
via: SeekingAlpha at 2019-06-11 04:13:28:000
Achieve Life Sciences (NASDAQ: ACHV ) is up 16% premarket on robust volume in response to results from the Phase 2 ORCA-1 dose-selection study of cytisinicline for smoking cessation. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Cons… read more...
Achieve Life Sciences up 16% premarket on positive cytisinicline data
via: SeekingAlpha at 2019-06-11 04:13:28:000
Achieve Life Sciences (NASDAQ: ACHV ) is up 16% premarket on robust volume in response to results from the Phase 2 ORCA-1 dose-selection study of cytisinicline for smoking cessation. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Cons… read more...
Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial
via: PR Newswire at 2019-06-11 03:00:00:000
3.0 mg, 3 times daily selected as dose for future clinical development SEATTLE and VANCOUVER, British Columbia , June 11, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company focused on nicotine addiction, today announced posi… read more...
Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial
via: PR Newswire at 2019-06-11 03:00:00:000
3.0 mg, 3 times daily selected as dose for future clinical development SEATTLE and VANCOUVER, British Columbia , June 11, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company focused on nicotine addiction, today announced posi… read more...
Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial
via: PR Newswire at 2019-06-11 03:00:00:000
3.0 mg, 3 times daily selected as dose for future clinical development SEATTLE and VANCOUVER, British Columbia , June 11, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company focused on nicotine addiction, today announced posi… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2017-08-03 | 11.0 | 1.0 | 11.0 |